Leveraging a powerful allogeneic dendritic cell line towards neoantigen-based cancer vaccines

In recent years, immunotherapy has finally found its place in the anti-cancer therapeutic arsenal, even becoming standard of care as first line treatment for metastatic forms. The clinical benefit provided by checkpoint blockers such as anti-PD-1/PD-L1 in many cancers revolutionized the field. Howev...

Descripción completa

Detalles Bibliográficos
Autores principales: Hannani, Dalil, Leplus, Estelle, Laulagnier, Karine, Chaperot, Laurence, Plumas, Joël
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2023
Materias:
Research Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9886307/
https://www.ncbi.nlm.nih.gov/pubmed/36726965
http://dx.doi.org/10.18632/genesandcancer.229

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9886307/
https://www.ncbi.nlm.nih.gov/pubmed/36726965
http://dx.doi.org/10.18632/genesandcancer.229

Ejemplares similares